Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Alzheimers Disease, Familial: early-phase trial registry

2 of 5 indexed Alzheimers Disease, Familial trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Alzheimers Disease, Familial: 5 US clinical trials tracked, 2 recruiting.

Alzheimers Disease, Familial is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 5 of these trials.

Enrollment posture brief

Registry condition alzheimers-disease-familial

OPEN 2 | RECR 40% | LATE 1 | EARLY 4 | RANK #3391 | SPON 5

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Alzheimers Disease, Fami (th…40%
Open-enrollment share among volume-matched conditions near Alzheimers Disease, Familial

Alzheimers Disease, Familial lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Alzheimers Disease, Familial on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Alzheimers Disease, Familial is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Alzheimers Disease, Familial research.

    Washington University School of Medicine accounts for 5 of 5 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.

  3. Typical Alzheimers Disease, Familial enrolment sits around 280 participants.

    Median target enrolment is 280 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Alzheimers Disease, Familial research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 24Phase 31

Phase Distribution

PhaseTrial count
Phase 2 4
Phase 3 1

Named interventions

Most-linked intervention names on Alzheimers Disease, Familial records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Matching Placebo (Remternetug) Drug
2 trials
lecanemab Drug
1 trials
Matching Placebo (Solanezumab) Drug
1 trials
Matching Placebo (Gantenerumab) Drug
1 trials
Solanezumab Drug
1 trials
Gantenerumab Drug
1 trials
Matching Placebo (E2814) Drug
1 trials
E2814 Drug
1 trials

US sites by state

Facility locations filed on Alzheimers Disease, Familial trials. A trial with sites in several states counts in each.

Washington 5 trials
Missouri 5 trials
Indiana 5 trials
Alabama 5 trials
Texas 4 trials
Rhode Island 4 trials
Pennsylvania 4 trials
Illinois 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Alzheimers Disease, Familial page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alzheimers Disease, Familial condition card totals 5 registered trials; most-linked intervention Matching Placebo (Remternetug); top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.